Collectively, these results indicate that the absence of JARID1D modulates the activities of both osteoclasts and osteoblasts, affects bone resorption and bone remodeling triggered by osteolytic activity, and consequently promotes the progression of PCa bone metastases. The gene discussed is KDM5D; the disease is posterior cortical atrophy.